BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Elsevier Business Intelligence to Host Investment in Innovation (IN3) Medical Device 360 Degrees Dublin, April 16-18, 2013


1/22/2013 9:09:37 AM

DUBLIN, IRELAND--(Marketwire - January 22, 2013) - Elsevier Business Intelligence, publisher of "The Gray Sheet" and the medtech industry's leading provider of strategic partnership and investment conferences, announced today that it will host the 'Investment in Innovation (IN3) Medical Device 360 degrees Dublin' partnering and investment conference on April 16-18, 2013, at the The Shelbourne Dublin. This special event will bring together a diverse group of medtech's key thought leaders -- from among Corporate Business Development execs, Venture Capital and Angel investors, Start-Up Entrepreneurs and Industry Pioneers -- to candidly discuss the critical issues that will define the future of all participants in the medical device space.

IN3 Dublin will feature presentations by more than 25 early-, mid- and late-stage start-up companies that are seeking funding and/or strategic partnership across the spectrum of diagnostic and therapeutic device markets. The conference also will feature an outstanding agenda of panel discussions with expert guest speakers, including: Edward Andrle, VP Business Development, Sorin Group; Dennis Crowley, VP Corporate Development & Licensing, Covidien; Townsend Goddard, Director of Business Development & Strategic Planning, Stryker Corporation; Dr. Thomas Fogarty, Founder, Fogarty Institute for Innovation; Alan O'Connell, Ph.D., Partner, Seroba Kernel Lifesciences; Antoine Papiernik, Managing Partner, Sofinnova Partners; Timothy Haines, Partner, Abingworth Management; Thom Rasche, Partner, Earlybird Venture Capital; John E. Milad, Investment Manager, NBGI Ventures; Ena Prosser, Partner, Fountain Healthcare Partners; Dr. Joey Mason, Partner, Delta Partners; and Simon Cartmell, Venture Partner, Imperial Innovations. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.

This two-day special event will benefit a wide variety of participants in the medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. Emerging medtech companies that would like to apply to present in Dublin should contact Kayleen Kell at 949-797-7142, or email k.kell@elsevier.com.

In addition to all of the customary conference benefits, presenting company CEOs will have the opportunity to be interviewed on camera, at no charge, for a 3-minute exclusive video in which they may discuss their company and technology. These interviews will be featured post-conference at www.in3tv.com, to which a link will be provided to participating companies for their unrestricted use; availability of these video interviews will be broadly promulgated within the medtech industry. All one-on-one interviews with presenting-company CEOs will take place at, and during, the IN3 Dublin conference and be organized by medtech PR/IR expert Ronald Trahan, President of Ronald Trahan Associates, Inc. Videotaping will take place on a scheduled basis only, on one day only of the event: Wednesday, April 17, from 13:00-17:30 local time. To schedule the free on-camera interviews contact rctrahan@ronaldtrahan.com, or call +1-508-359-4005, x108.

IN3 Medical Device 360 degrees Dublin will be held at The Shelbourne Dublin. Event co-sponsors include Ronald Trahan Associates Inc., Aptiv Solutions, Enterprise Ireland, Eugene F. Collins, KPMG, Medmarc with The Hartford and Biomedic-Insure, Seroba Kernel, and marketwire. Visit www.in3dublin.com for full conference and registration details.

About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.


Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES